Recombinant human hyaluronidase PH20 (rHuPH20) facilitates subcutaneous infusions of large volumes of immunoglobulin in a swine model

Cutaneous Tactile Allodynia Associated with Microvascular Dysfunction in Muscle

(2012) Andre Laferrière et al.   Molecular Pain

Efficacy and safety of home-based subcutaneous immunoglobulin replacement therapy in paediatric patients with primary immunodeficiencies

(2011) M. Borte et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies

(2011) Nima Rezaei et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Threshold Model for Extremity Compartment Syndrome in Swine

(2011) John Kalns et al.   JOURNAL OF SURGICAL RESEARCH

Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficiencies

(2010) R. Gustafson et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Regulatory acceptability of the minipig in the development of pharmaceuticals, chemicals and other products

(2010) Jan Willem van der Laan et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

Subcutaneous immunoglobulin: opportunities and outlook

(2009) S. Misbah et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Quantitative structure–property relationship modeling of skin sensitization: A quantitative prediction

(2009) Sharath Golla et al.   TOXICOLOGY IN VITRO

Subcutaneous Administration of IgG

(2008) Melvin Berger   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA